Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects



Rating:

Share or cite this content

Citations should be made in the following way:
J. Paluero (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), M. Labor (Värnamo, Sweden). Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor. 961

Member's Comments

No comment yet.

Related content which might interest you: Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020 The role of infections in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 One-year follow up of patients hospitalized for acute exacerbation of COPD related to viral infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Is RSV positive testing predictive of a more severe course of disease in patients with acute bronchiolitis admitted to hospital? Source: Eur Respir J 2005; 26: Suppl. 49, 627s Year: 2005 Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors Source: Eur Respir J 2005; 26: Suppl. 49, 628s Year: 2005 The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 277s Year: 2002 Response to non-invasive ventilation as a predictor for mortality in patients with acute respiratory failure due to acute exacerbation of COPD Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure Year: 2017 Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004 Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk. Source: International Congress 2017 – Latest insights into chronic care Year: 2017 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma? Source: Eur Respir J 2001; 18: Suppl. 33, 73s Year: 2001 The role of viral infections in patients admitted with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004 Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020 Year: 2021 Correspondence between clinical prediction and outcome in patients with acute hypercapnic respiratory failure (AHRF) due to restrictive lung disease Source: Annual Congress 2012 - Application of noninvasive ventilation in non-obstructive patients Year: 2012 The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded) Source: Eur Respir Mon; 2008: 41: 60–71 Year: 2008